What is the deadliest cancer
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
The Deadliest Cancer: A Comprehensive Overview
Pancreatic Cancer: The Silent Killer
Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), is widely recognized as one of the deadliest forms of cancer. It is characterized by a very low five-year survival rate of about 6%, which is consistent across both developed and developing countries. The high mortality rate is attributed to late-stage diagnosis and significant therapeutic resistance. In 2012, pancreatic cancer caused over 331,000 deaths globally, making it the seventh leading cause of cancer death. The incidence and mortality rates are notably higher in developed countries, with risk factors including smoking, obesity, genetics, diabetes, and diet .
Glioblastoma: Aggressive Brain Cancer
Glioblastoma, a type of glioma, is another highly lethal cancer. Most of the 20,000 people diagnosed annually in the United States with glioblastoma die within two years due to the tumor's aggressive invasion of surrounding brain tissue. Recent genetic studies have identified numerous mutations in glioblastoma, with an average of 60 altered genes per tumor, which complicates treatment. Despite advances in understanding its genetic makeup, glioblastoma remains challenging to treat effectively.
Hepatocellular Carcinoma: Liver Cancer Challenges
Hepatocellular carcinoma (HCC), or malignant hepatoma, is also among the deadliest cancers. Its complexity, high recurrence rate after surgical resection, and propensity for metastasis contribute to its high mortality. Factors such as chronic alcohol consumption, viral hepatitis B and C infections, and metabolic disorders are known to trigger HCC. Although various treatment modalities exist, including transcatheter arterial chemoembolization and radiotherapy, the prognosis remains poor.
Epithelial Ovarian Cancer: Leading Gynecologic Malignancy
Epithelial ovarian cancer is the deadliest gynecologic malignancy and the fourth most common cause of cancer death in women in the United States. With over 14,500 deaths annually, it poses a significant health challenge. The overall lifetime risk for developing epithelial ovarian cancer is 1.7%, but this risk increases with familial history.
Small Cell Lung Cancer: A Lethal Lung Cancer
Small cell lung cancer (SCLC) accounts for nearly 15% of all lung cancers and is one of the deadliest malignancies. The prognosis for SCLC is generally poor due to its aggressive nature and tendency to metastasize early. Comprehensive genomic profiling has revealed significant insights into the genetic landscape of SCLC, which may inform future therapeutic strategies.
Colorectal Cancer: The Importance of Early Detection
Colorectal cancer (CRC) ranks as the fourth most common cause of cancer-related deaths worldwide. Its lethality is primarily due to late-stage diagnosis, often when the cancer has metastasized. Current research is focused on developing non-invasive, reliable screening methods, such as microRNA diagnostic markers, to improve early detection and treatment outcomes.
Conclusion
Pancreatic cancer, glioblastoma, hepatocellular carcinoma, epithelial ovarian cancer, small cell lung cancer, and colorectal cancer are among the deadliest cancers, each presenting unique challenges in diagnosis and treatment. Advances in genetic and molecular profiling are crucial for developing targeted therapies and improving survival rates. Early detection and prevention remain key strategies in combating these lethal diseases.
Sources and full results
Most relevant research papers on this topic